Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in African Americans: The Jackson Heart Study

Frontiers in Public Health

Volumn 1, Issue MAY, 2013, Pages

  Bidulescu, Aurelian ^a   Liu, Jiankang ^b   Chen, Zhimin ^c   Hickson, DeMarc A ^b,d   Musani, Solomon K ^b   Samdarshi, Tandaw E ^b   Fox, Ervin R ^b   Taylor, Herman A ^b,d   Gibbons, Gary H ^e  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d JACKSON STATE UNIVERSITY   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Adiponectin; African Americans; Cardiovascular events; Cohort study; Leptin; Minorities; Stroke

Indexed keywords

EID: 84975104695     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2013.00016     Document Type: Article

References (53)

1. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular dis- ease. Nature (2006) 444:875-80. doi:10.1038/nature05487
2. Funahashi T, Matsuzawa Y. Metabolic syndrome: clinical concept and molecular basis. Ann Med (2007) 39:482-94. doi:10.1080/07853890701491026
3. Wannamethee SG, Tcher- nova J, Whincup P, Lowe GD, Kelly A, Rumley A, et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Ath- erosclerosis (2007) 191:418-26. doi:10.1016/j.atherosclerosis.2006. 04.012
4. Soderberg S, Stegmayr B, Sten- lund H, Sjostrom LG, Agren A, Johansson L, et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med (2004) 256:128-36. doi:10.1111/j.1365- 2796.2004.01351.x
5. Sierra-Johnson J, Romero-Corral A, Lopez-Jimenez F, Gami AS, Sert Kuniyoshi FH, Wolk R, et al. Relation of increased lep- tin concentrations to history of myocardial infarction and stroke in the United States population. Am J Cardiol (2007) 100:234- 9. doi:10.1016/j.amjcard.2007.02. 088
6. McNeelyMJ, Boyko EJ,Weigle DS, Shofer JB, Chessler SD, Leonnetti DL, et al. Association between baseline plasma leptin levels and subsequent development of dia- betes in Japanese Americans. Diabetes Care (1999) 22:65-70. doi:10.2337/diacare.22.1.65
7. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation (2001) 104:3052-6. doi:10.1161/hc5001.101061
8. Beltowski J. Leptin and atherosclerosis. Atheroscle- rosis (2006) 189:47-60. doi:10.1016/j.atherosclerosis.2006. 03.003
9. Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep (2008) 10:131-7. doi:10.1007/s11906-008-0025-y
10. Shibata R, Ouchi N, Murohara T.Adiponectin and cardiovascular disease. Circ J (2009) 73:608-14. doi:10.1253/circj.CJ-09-0057
11. Hopkins TA, Ouchi N, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res (2007) 74:11-8. doi:10.1016/j.cardiores.2006.10. 009
12. Kanaya AM, Wassel Fyr C, Vit- tinghoff E, Havel PJ, Cesari M, Nicklas B, et al. Serumadiponectin and coronary heart disease risk in older Black andWhite Americans. J Clin Endocrinol Metab (2006) 91:5044-50. doi:10.1210/jc.2006- 0107
13. Kizer JR, Benkeser D, Arnold AM, Mukamal KJ, Ix JH, Zieman SJ, et al. Associations of total and high- molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the cardiovascular health study. Circulation (2012) 126:2951-61. doi:10.1161/CIRCULATIONAHA. 112.135202
14. Bidulescu A, Liu J, Hickson DA, Hairston KG, Fox ER, Arnett DK, et al. Gender differences in the association of visceral and subcutaneous adiposity with adiponectin inAfricanAmericans: the Jackson Heart Study. BMC Cardiovasc Disord (2013) 13:9. doi:10.1186/1471-2261-13-9
15. Laughlin GA, Barrett-Connor E, May S, Langenberg C. Associa- tion of adiponectin with coro- nary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol (2007) 165:164-74. doi:10.1093/aje/kwk001
16. Karakas M, Zierer A, Herder C, Baumert J, Meisinger C, Koenig W, et al. Leptin, adiponectin, their ratio and risk of Coro- nary Heart Disease: results from the MONICA/KORA Augsburg Study 1984-2002. Atherosclerosis (2010) 209:220-5. doi:10.1016/j.atherosclerosis.2009. 08.020
17. Kizer JR, Benkeser D, Arnold AM, Djousse L, Zieman SJ, Mukamal KJ, et al. Total and high- molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. J Clin Endocrinol Metab (2013) 98:255-63. doi:10.1210/jc.2012-2103
18. Taylor HA Jr. The Jackson Heart Study: an overview. Ethn Dis (2005) 15:S6-1-3.
19. Carpenter MA, Crow R, Steffes M, Rock W, Heilbraun J, Evans G, et al. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci (2004) 328:131-44. doi:10.1097/00000441- 200409000-00001
20. Wyatt SB,DiekelmannN,Hender- son F, Andrew ME, Billingsley G, Felder SH, et al. A community- driven model of research par- ticipation: the Jackson Heart Study Participant Recruitment and Retention Study. Ethn Dis (2003) 13:438-55.
21. Keku E, Rosamond W, Taylor HA Jr., Garrison R,Wyatt SB, Richard M, et al. Cardiovascular disease event classification in the Jackson Heart Study: methods and proce- dures. Ethn Dis (2005) 15:S6-62- 70.
22. Liu J, Butler KR, Buxbaum SG, Sung JH, Campbell BW, Taylor HA. Leptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study. Clin Endocrinol (Oxf) (2009) 72(1):32-7. doi:10.1111/j.1365- 2265.2009.03627.x
23. Bidulescu A, Liu J,Musani SK, Fox ER, Samdarshi TE, Sarpong DF, et al. Association of adiponectin with left ventricular mass in blacks: the Jackson Heart Study. Circ Heart Fail (2011) 4:747-53. doi:10.1161/CIRCHEARTFAILU RE.110.959742
24. Dubbert PM, Carithers T, Ainsworth BE, Taylor HA Jr., Wilson G, Wyatt SB. Physical activity assessment methods in the Jackson Heart Study. Ethn Dis (2005) 15:S6-56-61.
25. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest (2006) 116:1784-92. doi:10.1172/JCI29126
26. Szmitko PE, Teoh H, Stewart DJ, Verma S. Adiponectin and car- diovascular disease: state of the art? Am J Physiol Heart Circ Physiol (2007) 292:H1655-63. doi:10.1152/ajpheart.01072.2006
27. Pischon T, Rimm EB. Adiponectin: a promising marker for cardiovascular dis- ease. Clin Chem (2006) 52:797-9. doi:10.1373/clinchem.2006.067819
28. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB. Adiponectin and future coronary heart disease events amongmenwith type 2 dia- betes. Diabetes (2005) 54:534-9. doi:10.2337/diabetes.54.2.534
29. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B. Serum adiponectin is a predic- tor of coronary heart disease: a population-based 10-year follow- up study in elderly men. J Clin Endocrinol Metab (2007) 92:571- 6. doi:10.1210/jc.2006-1067
30. Lindsay RS, Resnick HE, Zhu J, Tun ML, Howard BV, Zhang Y, et al. Adiponectin and coro- nary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol (2005) 25:e15-6. doi:10.1161/01.ATV.0000153090. 21990.8c
31. Sattar N,Wannamethee G, Sarwar N, Tchernova J, Cherry L,Wallace AM, et al. Adiponectin and coronary heart disease: a prospec- tive study and meta-analysis. Circulation (2006) 114:623-9. doi:10.1161/CIRCULATIONAHA. 106.618918
32. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Lowel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-agedmen: results fromthe 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol (2006) 48:1369-77. doi:10.1016/j.jacc.2006.06.053
33. Pischon T, Girman CJ, Hotamis- ligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 291:1730-7. doi:10.1001/jama.291.14.1730
34. Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, et al. Low plasma adiponectin levels pre- dict progression of coronary artery calcification. Circu- lation (2005) 111:747-53. doi:10.1161/01.CIR.0000155251. 03724.A5
35. Lawlor DA, Davey Smith G, Ebrahim S, Thompson C, Sattar N. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab (2005) 90:5677-83. doi:10.1210/jc.2005- 0825
36. Kuller LH, Grandits G, Cohen JD, Neaton JD, Prineas R. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis (2007) 195:122-8. doi:10.1016/j.atherosclerosis.2006. 09.001
37. HungWC,Wang CP, Lu LF,Yu TH, Chiu CA, Chung FM, et al. Cir- culating adiponectin level is asso- ciated with major adverse cardio- vascular events in type 2 diabetic patients with coronary artery dis- ease. Endocr J (2010) 57:793-802. doi:10.1507/endocrj.K10E-020
38. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. J Clin EndocrinolMetab (2008) 93:3357- 64. doi:10.1210/jc.2008-0640
39. Matsumoto M, Ishikawa S, Kajii E. Association of adiponectin with cerebrovascular dis- ease: a nested case-control study. Stroke (2008) 39:323-8. doi:10.1161/STROKEAHA.107. 497552
40. Khalili P, Flyvbjerg A, Frystyk J, Lundin F, Jendle J, Engstrom G, et al. Total adiponectin does not predict cardiovascular events in middle-aged men in a prospec- tive, long-term follow-up study. DiabetesMetab (2010) 36:137-43. doi:10.1016/j.diabet.2009.10.004
41. Ogorodnikova AD, Wassertheil- Smoller S, Mancuso P, Sowers MR, Rajpathak SN, Allison MA, et al. High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study. Stroke (2010) 41:1376-81. doi:10.1161/STROKEAHA.109. 576546
42. Drechsler C, Krane V, Win- kler K, Dekker FW, Wanner C. Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mor- tality in hemodialysis patients. Kidney Int (2009) 76:567-75. doi:10.1038/ki.2009.200
43. Pischon T, Hu FB, Girman CJ, Rifai N, Manson JE, Rexrode KM, et al. Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Ath- erosclerosis (2011) 219:322-9. doi:10.1016/j.atherosclerosis.2011. 07.011
44. Soderberg S,Ahren B, Stegmayr B, Johnson O, Wiklund PG, Weine- hall L, et al. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke (1999) 30:328-37. doi:10.1161/01.STR.30.2.328
45. Soderberg S, Stegmayr B,Ahlbeck- Glader C, Slunga-Birgander L, Ahren B, Olsson T. High leptin levels are associated with stroke. Cerebrovasc Dis (2003) 15:63-69. doi:10.1159/000067128
46. Sattar N, Watt P, Cherry L, Ebrahim S, Davey Smith G, Lawlor DA. High molecular weight adiponectin is not asso- ciated with incident coronary heart disease in older women: a nested prospective case- control study. J Clin Endocrinol Metab (2008) 93:1846-9. doi:10.1210/jc.2007-2603
47. Sattar N, Wannamethee G, Sar- war N, Chernova J, Lawlor DA, Kelly A, et al. Leptin and coro- nary heart disease: prospective study and systematic review. J AmCollCardiol (2009) 53:167-75. doi:10.1016/j.jacc.2008.09.035
48. Rajpathak SN, Kaplan RC, Wassertheil-Smoller S, Cushman M, Rohan TE, McGinn AP, et al. Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women's Health Initia- tive. Stroke (2011) 42:1813-20. doi:10.1161/STROKEAHA.110. 607853
49. Teoh H, Strauss MH, Szmitko PE, Verma S. Adiponectin and myocardial infarction: a paradox or a paradigm? Eur Heart J (2006) 27:2266-8. doi:10.1093/eurheartj/ehl248
50. Rathmann W, Herder C. Adiponectin and cardiovascular mortality: evidence for "reverse epidemiology". Horm Metab Res (2007) 39:1-2. doi:10.1055/s-2007-958630
51. Rathmann W, Haastert B, Herder C,HaunerH,KoenigW,Meisinger C, et al. Differential association of adiponectin with cardiovas- cular risk markers in men and women? The KORA survey 2000. Int J Obes (Lond) (2007) 31: 770-6.
52. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Paj- vani UB, et al. Adiponectin acts in the brain to decrease body weight. NatMed (2004) 10:524-9. doi:10.1038/nm0604-649a
53. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement- related protein of 30 kDa (Acrp30). J Biol Chem (2002) 277:29359-62. doi:10.1074/jbc. C200312200